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Summary
Atrial myxomas are the commonest cardiac neoplasms. The most common extra-cardiac manifestations are embolic infarcts from tumour
embolisation. Infrequently, aneurysm formation and intracranial haemorrhages also occur. Incredibly rare are space-occupying lesions and
malignant transformation. The authors report a case of a previously healthy middle-aged lady who developed recurrent and expanding
intraparenchymal haemorrhages following resection of a left atrial myxoma without any primary disease recurrence. The case described is
completely different from the described literature in that her intracranial vasculature was free of aneurysms on angiography despite central
nervous system haemorrhage and no myxomatous or malignant features were seen on histology of the resected symptomatic occipital lesion.
The authors compare this case to the available literature and also provide a literature review.

BACKGROUND
Tumours originating from the heart are a rarity with a
reported incidence between 0.0017 and 2.8% in various
autopsy series.1–4 Most are true neoplasms, albeit benign,
with myxomas accounting for more than half of these.1 3 5–
9 Myxomas are usually solitary and the most frequent site
for a myxoma is the left atrium.3 4 10–11 Systemic embolisation is a common complication with the brain harbouring
majority of these metastases.4 6 9 12 13 The intracranial manifestations observed include embolic infarcts, aneurysms,
central nervous system (CNS) lesions and haemorrhage.
Complete surgical resection is often curative in those with
intracardiac disease alone. Although recurrence is rare, it is
usually seen after embolisation of primary tumour, after an
incomplete resection or in familial cases.8 9 14–16
We report a case of a middle-aged female who developed non-aneurysmal, non-myxomatous intraparenchymal haemorrhagic sequelae following successful resection
of her atrial myxoma.
We feel this is important to report for the following reasons: the patient did not have aneurysms and yet developed
multi-focal CNS haemorrhage. Additionally, no malignant
myxomatous features were reported on the histopathology
of her CNS lesion after resection and yet she demonstrated
repeated worsening of intracranial haemorrhage (ICH) in a
naturally malignant course (ﬁgure 1).

CASE PRESENTATION
A 47-year-old previously healthy lady ﬁrst presented to the
emergency room in October 2010 with a new-onset chest
pain along with dyspnoea and associated with off and on
low-grade fever for the last 4 weeks. On examination, she
was a middle-aged lady with average height and built, afebrile but with a mild tachypnoea. She was neurologically
intact.
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On initial presentation, the erythrocyte sedimentation rate was 38. Her arterial blood gases, urea and electrolytes, coagulation proﬁle and liver function tests were
unremarkable. Her chest x-ray did not reveal any abnormality. No neuroimaging was done at this stage as it was
unwarranted.
A transthoracic echocardiogram (TTE) revealed a mobile,
pedunculated, echogenic mass in the left atrium attached
to the intra-atrial septum, 6×3×4 cm in size and causing
mitral inﬂow obstruction. She then underwent surgical
resection of the mass. She went home 5 days later in a
stable condition. A postoperative TTE showed no residual
mass. The ﬁnal histopathology report revealed the mass to
be a benign atrial myxoma.
Four months after this surgery, the patient presented
in the emergency department in generalised tonic-clonic
status epilepticus. A MRI of her brain revealed multiple
hyper-intense lesions with surrounding oedema in the
cerebellar and cerebral hemispheres bilaterally with no
postcontrast enhancement. However, her repeat echocardiogram showed no new or residual atrial mass. A cerebral CT angiography was negative for presence of arterial
aneurysms.
She was conservatively managed with phenytoin for her
seizures and discharged. Two months later, she was again
admitted through emergency for breakthrough seizures
and drowsiness of 1 day. A cranial MRI done this time redemonstrated multiple haemorrhagic lesions in the brain
which had increased in number and size. The largest, in
the left occipital lobe, measured 22.7×17.1 mm. There was
also subtle postcontrast enhancement seen now. A conventional cerebral angiogram done to evaluate the intracranial
vasculature again was normal (ﬁgure 2). Her echocardiogram was also negative for recurrence. A CAT scan of her
chest, abdomen and pelvis revealed no metastatic disease.
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Figure 1

Serial neuroimaging showing expanding intracranial haemorrhage.

She got a neurosurgical evaluation. Lamotrigine was
added to her antiepileptic regimen. She was discharged
when her serum valproate and phenytoin levels were
within desirable range.
Although her seizures were controlled on the new
regimen, in 2 months’ time, she was readmitted with progressive right-sided weakness, drowsiness and visual disturbance. Neurological examination revealed a visual ﬁeld
defect, papilloedema and a 4/5 motor power in the right
extremities and alexia without agraphia.
To evaluate the status of her brain, an MRI was repeated
which showed a growing contrast-enhancing, space-occupying left occipital haemorrhagic lesion, measuring 5.4×2.3
cm and causing a midline shift.
She underwent a craniotomy and excision of this lesion
and her status improved subsequently. The histology of
the lesion was not consistent with that of atrial myxoma
and it was reported as a haemorrhagic infarct. There were
no inﬂammatory cells in the lesion.
She left home stable, with a visual ﬁeld deﬁcit, subtle
memory difﬁculties and complete recovery of her right
hemiparesis.
Three months after her craniotomy, she was brought in
with complaints of drowsiness, headache and vomiting.
She was unable to walk and had developed central ataxia.
A cerebral MRI redemonstrated multiple cerebral and cerebellar haemorrhagic lesions, with the latter having grown
considerably since previous imaging. Neurosurgical evaluation was done, however given the size and multiplicity of
lesions, she was declared unﬁt for surgery. As a desperate
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measure to reduce the intensity of her bleeding, in addition
to steroids, a short course of mannitol and symptomatic
therapy, she was also given oral tranexamic acid at 500 mg
four times a day for 3 days.
Within 24 h of administration, she became better. Her
vomiting and drowsiness improved. She became able to
walk with assistance and her mannitol was successfully
tapered off. At this point, despite no change in her lesion
status, she is at home with resumption of her daily activities and remains on a low dose of steroids (dexamethasone
2 mg daily).

OUTCOME AND FOLLOW-UP
At this point in writing, the patient remains stable with
steroids and is seeking radiotherapy opinion given this
review.

DISCUSSION
When symptomatic, atrial myxomas have obstructive,
metastatic and/or constitutional manifestations and most
frequently present with dyspnoea signifying some degree
of heart failure.5 9 13 17 Left atrial myxomas have a propensity to embolise haematogenously and get deposited in the
brain, bone, cartilage, skin, abdominal organs and soft tissues.6 9 13 Benign atrial myxomas are usually sporadic with
less than one-ﬁfth of the cases being familial as reported in
literature.3 Although rare, these familial cases tend to pose
a bigger challenge because they are often multiple, have
variable resistance to treatment, a higher risk of recurrence
and early age at presentation.3 14 15
BMJ Case Reports 2012; doi:10.1136/bcr.02.2012.5772
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Mass
Mass

Enhancing low density
mass
Intracranial mass

Infarct/ring-enhancing
mass
Multiple high density
enhancing
Mycotic aneurysms

SOL

Mass lesion
Enhancing subcortical
lesion
High density lesions
Enhancing mass: partly
cystic
Enhancing mass

Metastases

Haemorrhagic
Soft tissue mass
Embolic infarct

Multiple enhancing nodules
Periventricular white matter
lesions, multiple nodular
lesions
Solid and cystic

Haemorrhagic

Type of brain lesion on
radiology

Clusters of spindle and stellate
cells
Myxoid stroma with inflammatory
cells
Myxoid invasion of neural tissue
Blood sinusoids with myxoid and
connective tissue

Myxomatous features

Myxomatous tissue

Myxoma tissue, haemosiderin,
fibrosis
Infiltrative cardiac myxoma

Metastatic atrial myxoma:
glandular variant
Benign intracerebral myxoma
Epithelioid haemangioendothelioma with myxoid features
Benign myxoma
Sarcoma with myxoid
degeneration
Malignant astrocytoma

Metastatic atrial myxoma

Metastatic atrial myxoma:
glandular variant
Benign embolic myxoma
Low-grade myxosarcoma

Haemorrhagic infarct, no
myxomatous features
Myxoma invading vascular wall

Type of brain lesion on HP

HP, histopathology; NA, not applicable; NR, not reported; NK, not known; SOL, space-occupying lesion.
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Reported in Age
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Author

Intracranial metastases of cardiac myxomas as reported in literature

S. No
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Figure 2

Four-vessel cerebral angiogram showing absence of aneurysms and vasculitis.

Familial syndromes with atrial myxomas include naevi,
atrial myxoma, myxoid neuroﬁbromata and ephelides, lentigines, atrial myxoma, mucocutaneous myxoma, and blue
naevi and the autosomal dominant Carney’s syndrome.
In cases where these are suspected due to presentation,
the family can be screened with TTE or genetic testing
depending upon availability.
Neurologic manifestations of atrial myxoma are common and include ischaemic events with myxomatous
fragments occluding or stenosing the small calibre intracerebral vasculature.18 19 This embolisation may occur
as part of the natural history or may be iatrogenic when
during resection and removal, a fragment dislodges.8
Moreover, although less common, arterial wall weakness
has also been described and is associated with both myxomatous and non-myxomatous aneurysm formation, often
years after resection of the primary tumour.4 6 9 13 18 19
Even less often seen are the haemorrhagic sequelae, both
intraparenchymal and subarachnoid bleeds subsequent to
rupture of these aneurysms.4 True metastasis and proliferation of extra-arterial myxomatous tissue is a rare phenomenon, at best.9 13
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The age, sex, location and initial presentation of atrial
myxoma in our patient correspond to that described in literature (table 1).3–5 9 11 13 17 20 However, she represents a rare
case where she had recurrent large cerebral parenchymal
haemorrhages mainly in the vertebrobasilar territory but also
involving the anterior circulation without any histological
evidence of myxomatous features in the lesions or any angiographic evidence of aneurysm in intracranial vessels. There
is paucity of data regarding this rare phenomenon.13 18 21
Intracranial haemorrhages occur secondary to aneurysm
formation.10 20 If and how often will non-aneurysmal
arteries bleed into the parenchyma cannot be predicted.22
Knepperet al have, in their series, reported one case of subarachnoid haemorrhage where the haemorrhage occurred
without angiographic evidence of aneurysms.13 We postulate that silent tumour embolisation occurred during
surgery and then manifested later with seizures and development space occupying lesion. This seems more probable
especially due to the fact that there was signiﬁcant load of
lesions in the territory of posterior circulation.23 24
The time from diagnosis of atrial myxoma to the appearance of intracranial aneurysms is also variable.4 Should
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serial cerebral angiography be done for detection is still a
matter of debate since the treatment modalities for these
aneurysms, whether aneurysmectomy or chemotherapy
with doxorubicin, have yielded inconclusive results.4 10
The treatment of spontaneous intraparenchymal bleed
remains supportive and preventive.25 There are no guidelines speciﬁc for bleeds due to atrial myxomas.1 In our
patient after surgical excision of the largest haemorrhagic
lesion, tranexamic acid was started to prevent rebleeding.
Although there is literature to support the use of tranexamic acid in patients with berry aneurysms and subarachnoid haemorrhage,26 27 we have employed the same
in the hope of preventing further episodes of non-aneurysmal intra-parenchymal haemorrhage at least as a temporising measure.28 It has been 2 months since the initiation of
this therapy with no new episode of parenchymal bleed,
although it is premature to predict future risk. How long
will the antiﬁbrinolytic effect of the 3-day course of tranexamic acid last can also not be predicted. In addition, it
cannot be ruled out that the effects of tranexamic acid was
due to chance, improving natural history or the use of concurrent medications to lower intracranial pressure.
The possibility of a concomitant disease like vasculitis
cannot entirely be ruled out, although the absence of stroke
and the expanding nature of each ICH over time, argues
against this theory. We were unable to ﬁnd evidence of
inﬂammatory cells in the resection lesion at biopsy which
further refutes this possibility although does not eliminate
it entirely.
In patients with intraparenchymal manifestations of
atrial myxoma, there are only four reported cases that
received brain radiation.1 8 29 30 Most recently, Moiyadi
et al described a patient who received 25Gy focal radiation following craniotomy and excision of lesion with no
residual neurological deﬁcit post treatment.30 Altundag et al
have also reported a case where a patient received 30 Gy
whole brain radiation for an embolised benign myxoma.
Previously, Bernet et al reported a patient who received
5000 Gy whole brain radiation along with chemotherapy
for myxomatous metastases with malignant features to
the brain and elsewhere; resolution of these lesions was
seen following treatment. The earliest report we could
ﬁnd was by Todo et al where a patient received 60Gy of
radiation for brain lesion. This patient, however, died of
cerebral herniation due to enlarging intracranial masses
within a year of treatment.29 We are now contemplating
radiation in our case; however, our patient’s histopathology of haemorrhagic infarct taken from the occipital location does not necessarily correlate with the intervention in
the literature.

FUTURE DIRECTIONS
It has been hypothesised that interleukin-6 may be responsible for the metastasising nature of the otherwise benign
cardiac myxomas.31 This is an area which can be looked at
in future. When atrial myxomas are associated with intracranial haemorrhage, further research is needed into haemostatic therapy, safety of surgery and irradiation especially
when aneurysms and malignant potential are not found as
in this case.
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Learning points
▶

▶

▶

▶

Atrial myxomas are the commonest cardiac tumours
with neurologic complications being the most frequent
extra-cardiac manifestations; familial atrial myxoma
syndromes exist.
The neurological sequelae include embolic infarcts,
aneurysms, intracranial bleed and space-occupying
lesions; in that order of frequency/
As in the described case, although rare, there may
be large intraparenchymal bleeds requiring excision,
without angiographic evidence of aneurysms.
Whole brain radiation may have a role in preventing
rebleeding and reducing the size of existing lesions
and the literature describes this for both benign and
malignant pathology.
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